SKB BIO-B(06990),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

06990 SKB BIO-B

Not Yet Opened 06-17 16:08:12

172.200

+9.000

+5.51%

High174.700	Low163.000	Vol361.80K
Open163.000	D1 Closing163.200	Amplitude7.17%
Mkt Cap38.37B	Tradable Cap22.43B	Total Shares222.84M
T/O61.48M	T/O Rate0.28%	Tradable Shares130.27M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO-B","latestPrice":172.2,"timestamp":1718611692019,"preClose":163.2,"halted":0,"volume":361800,"delay":0,"floatShares":130273005,"shares":222844099,"eps":-3.0553815378678997,"marketStatus":"Not Yet Opened","change":9,"latestTime":"06-17 16:08:12","open":163,"high":174.7,"low":163,"amount":61483730,"amplitude":0.071691,"askPrice":172.2,"askSize":400,"bidPrice":171.8,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.0553815378678997,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1718674200000},"marketStatusCode":0,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":163.2,"openAndCloseTimeList":[[1718587800000,1718596800000],[1718600400000,1718611200000]],"volumeRatio":1.264681,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06990","defaultTab":"news","newsList":[{"id":"2444152401","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Investigational New Drug Approval For Innovative Drug- Skb518 For Injection By Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2444152401","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2444152401?lang=en_us&edition=fundamental","pubTime":"2024-06-17 18:16","pubTimestamp":1718619387,"startTime":"0","endTime":"0","summary":"June 17 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd   :   * INVESTIGATIONAL NEW DRUG APPROVAL FOR INNOVATIVE DRUG- SKB518 FOR INJECTION BY NMPA Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06990"],"gpt_icon":0},{"id":"2443615633","title":"We Think Sichuan Kelun-Biotech Biopharmaceutical (HKG:6990) Can Easily Afford To Drive Business Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2443615633","media":"Simply Wall St.","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2443615633?lang=en_us&edition=fundamental","pubTime":"2024-06-14 08:31","pubTimestamp":1718325099,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/we-think-sichuan-kelun-biotech-biopharmaceutical-hkg6990-can","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["06990","BK1161"],"gpt_icon":0},{"id":"2433648127","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Placing Of New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2433648127","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2433648127?lang=en_us&edition=fundamental","pubTime":"2024-05-08 10:25","pubTimestamp":1715135151,"startTime":"0","endTime":"0","summary":"May 8  - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd   :   * PLACING OF NEW SHARES   * ENTERED INTO SUBSCRIPTION AGREEMENT   * KELUN PHARMACEUTICAL TO SUBSCRIBE FOR 4.4 MILLION CO SHARES AT OF RMB136.21 PER SHARE   * TO PLACE 3.6 MILLION SHARES AT PRICE OF HK$150.00 PER SHAREFurther company coverage:    ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06990"],"gpt_icon":0},{"id":"2432906813","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Key Product A400 (Ep0031) Cleared To Start Phase 2 By US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2432906813","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2432906813?lang=en_us&edition=fundamental","pubTime":"2024-05-03 22:22","pubTimestamp":1714746160,"startTime":"0","endTime":"0","summary":"May 3 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical   :   * KEY PRODUCT A400 (EP0031) CLEARED TO START PHASE 2 BY US FDAFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06990"],"gpt_icon":0},{"id":"2426473106","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Announces Subscription For Structured Deposits","url":"https://stock-news.laohu8.com/highlight/detail?id=2426473106","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2426473106?lang=en_us&edition=fundamental","pubTime":"2024-04-12 23:33","pubTimestamp":1712936004,"startTime":"0","endTime":"0","summary":"April 12  - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd   :   * SUBSCRIPTION FOR STRUCTURED DEPOSITS   * AGREED TO SUBSCRIBE FOR 2 STRUCTURED DEPOSITS IN PRINCIPAL AMOUNT OF RMB100 MILLION EACH   * SUBSCRIPTION OF 2 STRUCTURED DEPOSITS FROM BANK OF CHENGDU   * AGREED TO SUBSCRIBE FOR 3 STRUCTURED DEPOSITS OF RMB100 MILLION, RMB80 MILLION AND RMB300 MILLION   * SUBSCRIPTION OF 3 STRUCTURED DEPOSITS FROM CHINA MERCHANTS BANKFurther company coverage:    ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06990"],"gpt_icon":0},{"id":"2422349544","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Posts FY Loss RMB574.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2422349544","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2422349544?lang=en_us&edition=fundamental","pubTime":"2024-03-25 23:10","pubTimestamp":1711379434,"startTime":"0","endTime":"0","summary":"March 25 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd   :   * FY LOSS RMB574.1 MILLION VERSUS LOSS RMB616.1 MILLION   * FY REVENUE RMB1.54 BILLION, UP 91.6%Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;;))","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06990"],"gpt_icon":0},{"id":"2419491642","title":"China Healthcare Stocks Rally on Hopes for Govt Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2419491642","media":"Dow Jones","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2419491642?lang=en_us&edition=fundamental","pubTime":"2024-03-14 14:52","pubTimestamp":1710399120,"startTime":"0","endTime":"0","summary":"Chinese pharmaceutical stocks rose sharply Thursday on hopes for government support, with analysts citing an alleged draft proposal on drug innovation widely circulated online and on social media.Hangzhou Tigermed Consulting led the gains among CSI300 companies, hitting its maximum 20% daily limit on the Shenzhen Stock Exchange, while its Hong Kong shares were 19% higher.Shouyao Holdings  advanced 20%, Hinova Pharmaceuticals added 10% and Shanghai Medicilon gained 8.6% in China trade. Sichuan Kelun-Biotech Biopharmaceutical rose 13.5% in Hong Kong.The rally came after a document purportedly issued by state planner National Development and Reform Commission made the rounds online and on social media after the market closed on Wednesday.The document proposed government support for the development of innovative drugs in China, including through possible new funds for supplemental payments for innovative drugs, financing opportunities for loss-making startup biotech companies, support for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0216","BK0028","688202","688197","LU1146622755.USD","BK0077","688302","300347","BK4137","06990","LU1820825898.SGD","HCSG","BK0174","BK1161"],"gpt_icon":0},{"id":"2419652499","title":"BUZZ-Sichuan Kelun-Biotech jumps on progress of core product's development","url":"https://stock-news.laohu8.com/highlight/detail?id=2419652499","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2419652499?lang=en_us&edition=fundamental","pubTime":"2024-03-13 14:13","pubTimestamp":1710310424,"startTime":"0","endTime":"0","summary":"** Shares of Chinese drug producer Sichuan Kelun-Biotech Biopharmaceutical Co Ltd    jump as much as 15.4% to HK$135.80, highest and biggest one-day gain since March 4   ** Stock is the biggest gainer in Hang Seng Composite Index   ** Co says its core product SKB264 was recently granted Breakthrough Therapy Designation by the Center for Drug Evaluation of the National Medical Products Administration  of China for first-line treatment of breast cancer   ** Co also warns of the risk that SKB264 may not ultimately be successfully developed and commercialized    ** Hong Kong's healthcare index    slips 0.8%, while  Hang Seng Composite Index    rises 0.6% and Hang Seng Index  adds 0.7%   ** Stock up 30.7% YTD   ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06990"],"gpt_icon":0},{"id":"2418503573","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says A400 Granted Fast Track Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2418503573","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2418503573?lang=en_us&edition=fundamental","pubTime":"2024-03-11 21:33","pubTimestamp":1710164001,"startTime":"0","endTime":"0","summary":"March 11 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd   :   * A400 GRANTED FAST TRACK DESIGNATION BY US FOOD AND DRUG ADMINISTRATION Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","BK4104","FAST","BK4588","BK4567","BK4585"],"gpt_icon":0},{"id":"2417480958","title":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990): Are Analysts Optimistic?","url":"https://stock-news.laohu8.com/highlight/detail?id=2417480958","media":"Simply Wall St.","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2417480958?lang=en_us&edition=fundamental","pubTime":"2024-03-05 07:30","pubTimestamp":1709595028,"startTime":"0","endTime":"0","summary":"We feel now is a pretty good time to analyse Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.'s ( HKG:6990 ) business...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/sichuan-kelun-biotech-biopharmaceutical-co-ltd-hkg6990-are-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","06990"],"gpt_icon":0},{"id":"2416155551","title":"BUZZ-Kelun-Biotech hits record peak on inclusion in Shanghai-Hong Kong Stock Connect","url":"https://stock-news.laohu8.com/highlight/detail?id=2416155551","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2416155551?lang=en_us&edition=fundamental","pubTime":"2024-03-04 11:11","pubTimestamp":1709521909,"startTime":"0","endTime":"0","summary":"** Shares of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd  jump as much as 31.6% to HK$136.50, their highest since debut on July 11   ** Stock on course to snap three straight sessions of decline; fourth biggest pct gainer in Hang Seng Composite Index   ** The Chinese biopharmaceuticals and chemical raw materials producer says it has been included in the list of eligible shares in the Southbound Trading Link of the Shanghai-Hong Kong Stock Connect, effective March 4    ** Co says the inclusion in Shanghai-Hong Kong Stock Connect will facilitate expansion of its shareholder base and increase the trading liquidity of the shares   ** Hong Kong's healthcare index    rises 2.9%, while Hang Seng Composite Index    and Hang Seng Index    both climb 0.2% ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06990"],"gpt_icon":0}],"profile":{"websiteUrl":"http://kelun-biotech.com","stockEarnings":[{"period":"1week","weight":-0.0342},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.1542},{"period":"6month","weight":0.6882},{"period":"1year","weight":1.8416},{"period":"ytd","weight":0.6735}],"compareEarnings":[{"period":"1week","weight":-0.0235},{"period":"1month","weight":-0.0827},{"period":"3month","weight":0.0851},{"period":"6month","weight":0.0796},{"period":"1year","weight":-0.105},{"period":"ytd","weight":0.0521}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sichuan Kelun Biotech Biopharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production, and sales of drugs. The Company is mainly engaged in the research and development, production, and sales of biopharmaceuticals, chemical raw materials, and chemical drug formulations. The Company's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, Gastrointestinal cancer and other non tumor diseases.","exchange":"SEHK","name":"SKB BIO-B","nameEN":"SKB BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.0","shortVersion":"4.24.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SKB BIO-B(06990),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SKB BIO-B(06990) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SKB BIO-B,06990,SKB BIO-B股票,SKB BIO-B股票老虎,SKB BIO-B股票老虎国际,SKB BIO-B行情,SKB BIO-B股票行情,SKB BIO-B股价,SKB BIO-B股市,SKB BIO-B股票价格,SKB BIO-B股票交易,SKB BIO-B股票购买,SKB BIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SKB BIO-B(06990),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SKB BIO-B(06990) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}